Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States
Abstract The impact of overlapping risk factors on coronavirus disease (COVID-19) severity is unclear. To evaluate the impact of type 2 diabetes (T2D) and obesity on COVID-19 severity, we conducted a cohort study with 28,095 anonymized COVID-19 patients using data from the COVID-19 Research Database...
Guardado en:
Autores principales: | Wataru Ando, Takeshi Horii, Takayuki Uematsu, Hideaki Hanaki, Koichiro Atsuda, Katsuya Otori |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22d8377ae5ab46188a993ca338787581 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
por: Yasunari Yamashita, et al.
Publicado: (2021) -
The economic impact of obesity in the United States
por: Hammond R, et al.
Publicado: (2010) -
The economic impact of obesity in the United States
por: Ross A Hammond, et al.
Publicado: (2010) -
Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis
por: Takeshi Horii, et al.
Publicado: (2019) -
Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus
por: Stanley Perlman, et al.
Publicado: (2013)